Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Qiagen ( (QGEN) ) is now available.
Qiagen N.V., a prominent entity in the biotechnology sector, has been notified by the Netherlands Authority for the Financial Markets (AFM) regarding a significant voting rights announcement. The notification, dated May 14, 2025, involves BlackRock, Inc., which holds a substantial indirect capital interest and voting rights in Qiagen. This development underscores BlackRock’s significant influence within Qiagen, potentially impacting the company’s strategic decisions and stakeholder interests.
The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Average Trading Volume: 1,333,605
Technical Sentiment Signal: Sell
Current Market Cap: $9.28B
Find detailed analytics on QGEN stock on TipRanks’ Stock Analysis page.